Go Pro

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
AIM ImmunoTech Inc. stock logo
AIM
AIM ImmunoTech
$0.22
-4.8%
$0.26
$0.19
$2.98
$6.76M1.1913.14 million shs9.54 million shs
MTO
Metanor Resources Inc. (MTO.V)
C$0.58
C$0.58
C$0.46
C$0.82
C$59.13MN/A80,421 shs232,400 shs
10 Stocks Powering The Next AI Boom  Cover

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
AIM ImmunoTech Inc. stock logo
AIM
AIM ImmunoTech
+1.52%-0.60%-11.33%-49.29%-90.92%
MTO
Metanor Resources Inc. (MTO.V)
0.00%0.00%0.00%0.00%0.00%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
AIM ImmunoTech Inc. stock logo
AIM
AIM ImmunoTech
$0.22
-4.8%
$0.26
$0.19
$2.98
$6.76M1.1913.14 million shs9.54 million shs
MTO
Metanor Resources Inc. (MTO.V)
C$0.58
C$0.58
C$0.46
C$0.82
C$59.13MN/A80,421 shs232,400 shs
10 Stocks Powering The Next AI Boom  Cover

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
AIM ImmunoTech Inc. stock logo
AIM
AIM ImmunoTech
+1.52%-0.60%-11.33%-49.29%-90.92%
MTO
Metanor Resources Inc. (MTO.V)
0.00%0.00%0.00%0.00%0.00%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
AIM ImmunoTech Inc. stock logo
AIM
AIM ImmunoTech
2.50
Moderate Buy$9.003,954.05% Upside
MTO
Metanor Resources Inc. (MTO.V)
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
AIM ImmunoTech Inc. stock logo
AIM
AIM ImmunoTech
$90K75.09N/AN/A($2.99) per share-0.07
MTO
Metanor Resources Inc. (MTO.V)
C$26.37M2.24C$0.01 per share64.44C$0.20 per share2.97
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
AIM ImmunoTech Inc. stock logo
AIM
AIM ImmunoTech
-$13.96M-$24.68N/AN/AN/A-15,021.05%N/A-143.02%N/A
MTO
Metanor Resources Inc. (MTO.V)
N/A-C$0.27N/AN/AN/AN/AN/AN/AN/A

Latest RCDO, MTO, AIM, and ASY Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/7/2026Q2 2026
AIM ImmunoTech Inc. stock logo
AIM
AIM ImmunoTech
N/A-$0.43N/A-$0.43N/A$0.03 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
AIM ImmunoTech Inc. stock logo
AIM
AIM ImmunoTech
N/AN/AN/AN/AN/A
MTO
Metanor Resources Inc. (MTO.V)
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
AIM ImmunoTech Inc. stock logo
AIM
AIM ImmunoTech
N/A
2.11
2.11
MTO
Metanor Resources Inc. (MTO.V)
12.70
0.58
0.27

Institutional Ownership

CompanyInstitutional Ownership
AIM ImmunoTech Inc. stock logo
AIM
AIM ImmunoTech
12.02%
MTO
Metanor Resources Inc. (MTO.V)
N/A

Insider Ownership

CompanyInsider Ownership
AIM ImmunoTech Inc. stock logo
AIM
AIM ImmunoTech
0.95%
MTO
Metanor Resources Inc. (MTO.V)
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
AIM ImmunoTech Inc. stock logo
AIM
AIM ImmunoTech
2030.44 million30.15 millionNot Optionable
MTO
Metanor Resources Inc. (MTO.V)
18,000101.95 millionN/ANot Optionable

Recent News About These Companies

FEERF Freeport Resources Inc.
PJX Resources Inc. (PJX.V)
RGCO RGC Resources, Inc.
Taranis Resources Inc. (TRO.V)
Wilton Resources Inc. (WIL.V)
Mason Resources Inc. (MGPHF)
EOG Resources Inc
Pegasus Resources Inc. (PEGA.V)
ExGen Resources Inc. DOK Project: Mineralization Encountered in First 3 Holes
Labrador Resources Inc. (LTX.V)
CRI.V - Churchill Resources Inc.
RBX.V - Robex Resources Inc.
Northern Superior Resources Inc. (SUP.V)
JKS Resources Inc. Completes Drill Program

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
AIM ImmunoTech stock logo

AIM ImmunoTech NYSEAMERICAN:AIM

$0.22 -0.01 (-4.80%)
As of 01:39 PM Eastern
This is a fair market value price provided by Massive. Learn more.

AIM ImmunoTech Inc., an immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States. The company's lead product candidate is Ampligen, a drug of macromolecular ribonucleic acid molecules for the treatment of chronic fatigue syndrome (CFS). It is also developing Ampligen for the treatment of pancreatic, renal cell carcinoma, malignant melanoma, non-small cell lung, ovarian, breast, colorectal, and prostate cancers, as well as for myalgic encephalomyelitis, Hepatitis B, HIV, COVID-19, and post-COVID conditions. In addition, the company provides Alferon N Injection, an injectable formulation of natural alpha interferon to treat human papilloma viruses, and genital warts, a sexually transmitted disease. AIM ImmunoTech Inc. has agreements with Amarex Clinical Research LLC; University of Cagliari Dipartimento di Scienze della Vita e dell'Ambiente; Jubilant HollisterStier; Sterling Pharma Solutions; Erasmus University Medical Center Rotterdam; Azenova, LLC; and Alcami Corporation. The company was formerly known as Hemispherx Biopharma, Inc. and changed its name to AIM ImmunoTech Inc. in August 2019. AIM ImmunoTech Inc. was incorporated in 1966 and is headquartered in Ocala, Florida.

Metanor Resources Inc. (MTO.V) CVE:MTO

C$0.58 0.00 (0.00%)
As of 09/25/2018

Metanor Resources Inc. produces and sells gold in Canada. It also explores for and develops mining properties. The company primarily holds interests in the Bachelor mine and the Barry project, as well as approximately 15,000 hectares of exploration properties located in the mining-friendly jurisdiction of Québec. Metanor Resources Inc. was incorporated in 2003 and is headquartered in Val-d'Or, Canada.